by Escherichia coli or E. coli strain is a bacteria commonly found in the lower intestine of warm-blooded organisms. E. coli strains are used as an indicator of fecal contamination of water or food and as vectors for recombinant DNA techniques. E. coli strains have various applications in biotechnology including production of therapeutic proteins, enzymes, organic acids, and biofuels. With rising concerns over water scarcity and increasing cases of waterborne diseases, E. coli strains are increasingly being used for testing water quality and developing effective water treatment solutions. The global E. coli strain market offers various advantages such as time efficiency, reliable results, ease of use, and cost-effectiveness associated with water safety testing.
The global Escherichia Coli Strain Market is estimated to be valued at US$ 1.97 Bn in 2023 and is expected to exhibit a CAGR of 24.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the E. coli strain market is the development of rapid detection kits. Traditionally, testing water quality for the presence of E. coli involved time-consuming culturing and identification of bacterial colonies. However, rapid detection kits utilizing innovative techniques like polymerase chain reaction (PCR) and immunomagnetic separation have enabled results within hours rather than days. These rapid detection kits have gained considerable traction in applications involving monitoring of drinking water distribution networks and recreational water facilities where timely remediation is critical. Their ease of use and portable design have further increased popularity. Rapid advancement in detection technologies is expected to drive significant growth of the E. coli strain market.
Porter’s Analysis
Threat of new entrants: The biotechnology industry requires significant capital investments and strict regulations act as a barrier for new companies.
Bargaining power of buyers: Individual consumers have low bargaining power as they need to rely on the availability of specialized strains. However, large pharma companies can negotiate with suppliers on pricing and supply terms.
Bargaining power of suppliers: The market has few global players that supply specialized strains giving them significant bargaining power over pricing. However, suppliers still rely on buyers for continuous demand.
Threat of new substitutes: There are few alternatives for specialized Escherichia coli strains used in research and industrial applications. But new technologies can potentially disrupt certain applications over the long term.
Competitive rivalry: Major players compete on innovation, production scale, product differentiation and pricing. however, industry collaborations are also common given the niche focus areas.
Key Takeaways
The Global Escherichia Coli Strain Market Growth is expected to witness high over the forecast period driven by increasing R&D in biopharmaceuticals. North America currently dominates the market owing to presence of major players and increasing funding for cell-line development projects in the US and Canada.
Regional analysis: Asia Pacific is expected to be the fastest growing region during the forecast period. This can be attributed to increasing biopharmaceutical manufacturing in countries like China, India and investment by global players to expand operations in the region.
Key players: Key players operating in the Escherichia Coli Strain market are Veritas Technologies Llc., Actifio Inc., Veeam Softwares, Commvault Systems Inc., Symantec Corporation, Ca Technologies, Microsoft Corporation, Dell Technologies Inc., Ibm Corporation, and Hewlett Packard Enterprise. These players are focusing on developing customized strains, expanding production facilities and gaining regulatory approvals to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
